SOHO Insider leukemia podcast with Drs. O’Brien and Coombs
Listen to Susan O’Brien, MD, professor of medicine, and Catherine C. Coombs, MD, associate professor of medicine, both of the Chao Family Comprehensive
Leukemia
Chronic Lymphocytic Leukemia
News
SOHO Insider Podcast
Multiple Myeloma
Dr. Shulman discusses US cancer surveillance challenges
Lawrence N. Shulman, MD, a medical oncologist at the University of Pennsylvania’s Abramson Cancer Center, discussed US cancer surveillance challenges in a recent
Multiple Myeloma
New blood test diagnoses multiple myeloma noninvasively
A next-generation blood test is able to diagnosis and monitor multiple myeloma (MM) and its precursor conditions by utilizing single-cell sequencing to profile
News
New AI tool ‘DeepHeme’ improves blood cancer diagnosis
A new artificial intelligence (AI)-powered diagnostic tool, DeepHeme, is able to perform individual cell classifications with an accuracy comparable to human experts, according
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
Multiple Myeloma
News
Can radiation prime the immune system to fight blood cancer?
In 1953, a physician named RH Mole published a paper in the British Journal of Radiology describing a surprising phenomenon he called the
Multiple Myeloma
News
FDA extends review for DREAMM-7, DREAMM-8 therapy in myeloma
The US Food and Drug Administration (FDA) extended the review timeline for the Biologics License Application for the belantamab mafodotin combinations investigated in
SOHO 2025
Meeting News
Myelodysplastic Syndromes
News
SOHO Insider Podcast
SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025
Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, and Phillip Scheinberg, MD, president of the Society of
EHA 2025
Meetings / Conferences
News
Phase 1 subcutaneous blinatumomab safe, effective in R/R B-ALL
Elias Jabbour, MD, leukemia professor in the University of Texas MD Anderson Cancer Center, discusses the phase 1/2 expansion study of subcutaneous blinatumomab
EHA 2025
Myeloproliferative Neoplasms
Video Interviews
Novel therapy INCA in ET shows positive results in early-phase data
Lucia Masarova, MD, an assistant professor in the Department of Leukemia at the University of Texas MD Anderson, discusses the 2025 EHA late-breaking